Filtros de búsqueda

Lista de obras de Shudong Wang

CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?

artículo científico publicado en 2020

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia

scientific article published on 08 September 2018

Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update

scientific article published on 20 December 2018

Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?

artículo científico publicado en 2017

Discovery and Pharmacological Characterisation of a Novel Series of Highly Selective Inhibitors of Cyclin-Dependent Kinases 4 and 6 as Anticancer Agents.

artículo científico publicado en 2017

Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents

artículo científico publicado el 29 de octubre de 2010

Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.

artículo científico publicado en 2017

In Search of Novel CDK8 Inhibitors by Virtual Screening

artículo científico publicado en 2017

Synthesis and biological evaluation of benzyl styrylsulfonyl derivatives as potent anticancer mitotic inhibitors

artículo científico publicado el 17 de marzo de 2011

Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents

artículo científico publicado el 3 de octubre de 2012

Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors

scientific article published on 23 July 2019

Targeting CDK2 in cancer: challenges and opportunities for therapy

artículo científico publicado en 2019

Targeting Mnks for Cancer Therapy

artículo científico publicado el 1 de febrero de 2012